Institutional investors purchased a net $8.7 million shares of TEVA during the quarter ended June 2015, and now own 54.94% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OZ MANAGEMENT LP Bought 3.7 Million shares of Teva Pharmaceutical
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.1 Million shares of Teva Pharmaceutical
GLENVIEW CAPITAL MANAGEMENT LLC Bought 2.8 Million shares of Teva Pharmaceutical